| Year |
Citation |
Score |
| 2022 |
Fimereli D, Venet D, Rediti M, Boeckx B, Maetens M, Majjaj S, Rouas G, Marchio C, Bertucci F, Mariani O, Capra M, Bonizzi G, Contaldo F, Galant C, Van den Eynden G, et al. Timing evolution of lobular breast cancer through phylogenetic analysis. Ebiomedicine. 82: 104169. PMID 35882101 DOI: 10.1016/j.ebiom.2022.104169 |
0.38 |
|
| 2020 |
Gómez-Aleza C, Nguyen B, Yoldi G, Ciscar M, Barranco A, Hernández-Jiménez E, Maetens M, Salgado R, Zafeiroglou M, Pellegrini P, Venet D, Garaud S, Trinidad EM, Benítez S, Vuylsteke P, ... ... Van den Eynden G, et al. Inhibition of RANK signaling in breast cancer induces an anti-tumor immune response orchestrated by CD8+ T cells. Nature Communications. 11: 6335. PMID 33303745 DOI: 10.1038/s41467-020-20138-8 |
0.31 |
|
| 2020 |
Richard F, Majjaj S, Venet D, Rothé F, Pingitore J, Boeckx B, Marchiò C, Clatot F, Bertucci F, Mariani O, Galant C, Van den Eynden GG, Salgado R, Biganzoli E, Lambrechts D, et al. Characterization of stromal tumor-infiltrating lymphocytes and genomic alterations in metastatic lobular breast cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 32943456 DOI: 10.1158/1078-0432.CCR-20-2268 |
0.381 |
|
| 2020 |
Sonnenblick A, Salmon-Divon M, Salgado R, Dvash E, Pondé N, Zahavi T, Salmon A, Loibl S, Denkert C, Joensuu H, Ameye L, Van den Eynden G, Kellokumpu-Lehtinen PL, Azaria A, Loi S, et al. Reactive stroma and trastuzumab resistance in HER2-positive early breast cancer. International Journal of Cancer. PMID 31904863 DOI: 10.1002/ijc.32859 |
0.361 |
|
| 2019 |
Nederlof I, De Bortoli D, Bareche Y, Nguyen B, de Maaker M, Hooijer GKJ, Buisseret L, Kok M, Smid M, Van den Eynden GGGM, Brinkman AB, Hudecek J, Koster J, Sotiriou C, Larsimont D, et al. Comprehensive evaluation of methods to assess overall and cell-specific immune infiltrates in breast cancer. Breast Cancer Research : Bcr. 21: 151. PMID 31878981 DOI: 10.1186/S13058-019-1239-4 |
0.321 |
|
| 2019 |
Desmedt C, Pingitore J, Rothé F, Marchio C, Clatot F, Rouas G, Richard F, Bertucci F, Mariani O, Galant C, Fribbens C, O'Leary B, van den Eynden G, Salgado R, Turner NC, et al. mutations in metastatic lobular breast cancer patients. Npj Breast Cancer. 5: 9. PMID 30820448 DOI: 10.1038/s41523-019-0104-z |
0.329 |
|
| 2019 |
Smid M, Wilting S, Uhr K, Rodriguez-Gonzalez G, de Weerd V, Prager-Van der Smissen W, van der Vlugt-Daane M, van Galen A, Nik-Zainal S, Butler A, Martin S, Davies H, Staaf J, van de Vijver M, Richardson A, ... ... van den Eynden G, et al. The circular RNome of primary breast cancer. Genome Research. PMID 30692147 DOI: 10.1101/gr.238121.118 |
0.661 |
|
| 2019 |
Nik-Zainal S, Davies H, Staaf J, Ramakrishna M, Glodzik D, Zou X, Martincorena I, Alexandrov LB, Martin S, Wedge DC, Van Loo P, Ju YS, Smid M, Brinkman AB, Morganella S, ... ... Van den Eynden GG, et al. Author Correction: Landscape of somatic mutations in 560 breast cancer whole-genome sequences. Nature. PMID 30659290 DOI: 10.1038/S41586-019-0883-2 |
0.641 |
|
| 2018 |
Mayrhofer M, De Laere B, Whitington T, Van Oyen P, Ghysel C, Ampe J, Ost P, Demey W, Hoekx L, Schrijvers D, Brouwers B, Lybaert W, Everaert E, De Maeseneer D, Strijbos M, ... ... Van den Eynden G, et al. Cell-free DNA profiling of metastatic prostate cancer reveals microsatellite instability, structural rearrangements and clonal hematopoiesis. Genome Medicine. 10: 85. PMID 30458854 DOI: 10.1186/s13073-018-0595-5 |
0.563 |
|
| 2018 |
De Laere B, Oeyen S, Mayrhofer M, Whitington T, van Dam PJ, Van Oyen P, Ghysel C, Ampe J, Ost P, Demey W, Hoekx L, Schrijvers D, Brouwers B, Lybaert W, Everaert EG, ... ... Van den Eynden GG, et al. TP53 outperforms other androgen receptor biomarkers to predict abiraterone or enzalutamide outcome in metastatic castration-resistant prostate cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 30209161 DOI: 10.1158/1078-0432.Ccr-18-1943 |
0.555 |
|
| 2018 |
Ignatiadis M, Van den Eynden G, Roberto S, Fornili M, Bareche Y, Desmedt C, Rothé F, Maetens M, Venet D, Holgado E, McNally V, Kiermaier A, Savage HM, Wilson TR, Cortes J, et al. Tumor-Infiltrating Lymphocytes in Patients Receiving Trastuzumab/Pertuzumab-Based Chemotherapy: A TRYPHAENA Substudy. Journal of the National Cancer Institute. PMID 29788230 DOI: 10.1093/jnci/djy076 |
0.331 |
|
| 2018 |
Desmedt C, Salgado R, Fornili M, Pruneri G, Van den Eynden G, Zoppoli G, Rothé F, Buisseret L, Garaud S, Willard-Gallo K, Brown D, Bareche Y, Rouas G, Galant C, Bertucci F, et al. Immune Infiltration in Invasive Lobular Breast Cancer. Journal of the National Cancer Institute. PMID 29471435 DOI: 10.1093/jnci/djx268 |
0.397 |
|
| 2018 |
De Laere B, Oeyen S, Van Oyen P, Ghysel C, Ampe J, Ost P, Demey W, Hoekx L, Schrijvers D, Brouwers B, Lybaert W, Everaert E, Van Kerckhove P, De Maeseneer D, Strijbos M, ... ... Van den Eynden G, et al. Circulating tumor cells and survival in abiraterone- and enzalutamide-treated patients with castration-resistant prostate cancer. The Prostate. PMID 29431193 DOI: 10.1002/Pros.23488 |
0.562 |
|
| 2017 |
Sonnenblick A, Salgado R, Brohée S, Zahavi T, Peretz T, Van den Eynden G, Rouas G, Salmon A, Francis PA, Di Leo A, Crown JPA, Viale G, Daly L, Javdan B, Fujisawa S, et al. p-STAT3 in luminal breast cancer: Integrated RNA-protein pooled analysis and results from the BIG 2-98 phase III trial. International Journal of Oncology. PMID 29207087 DOI: 10.3892/Ijo.2017.4212 |
0.327 |
|
| 2017 |
Dieci MV, Radosevic-Robin N, Fineberg S, van den Eynden G, Ternes N, Penault-Llorca F, Pruneri G, D'Alfonso TM, Demaria S, Castaneda C, Sanchez J, Badve S, Michiels S, Bossuyt V, Rojo F, et al. Update on tumor-infiltrating lymphocytes (TILs) in breast cancer, including recommendations to assess TILs in residual disease after neoadjuvant therapy and in carcinoma in situ: a report of the International Immuno-Oncology Biomarker Working Group on Breast Cancer. Seminars in Cancer Biology. PMID 29024776 DOI: 10.1016/j.semcancer.2017.10.003 |
0.385 |
|
| 2017 |
van Dam PJ, van der Stok EP, Teuwen LA, Van den Eynden GG, Illemann M, Frentzas S, Majeed AW, Eefsen RL, Coebergh van den Braak RRJ, Lazaris A, Fernandez MC, Galjart B, Laerum OD, Rayes R, Grünhagen DJ, et al. International consensus guidelines for scoring the histopathological growth patterns of liver metastasis. British Journal of Cancer. PMID 28982110 DOI: 10.1038/Bjc.2017.334 |
0.643 |
|
| 2017 |
Jeschke J, Bizet M, Desmedt C, Calonne E, Dedeurwaerder S, Garaud S, Koch A, Larsimont D, Salgado R, Van den Eynden G, Willard Gallo K, Bontempi G, Defrance M, Sotiriou C, Fuks F. DNA methylation-based immune response signature improves patient diagnosis in multiple cancers. The Journal of Clinical Investigation. PMID 28714863 DOI: 10.1172/JCI91095 |
0.314 |
|
| 2017 |
Pruneri G, Lazzeroni M, Bagnardi V, Tiburzio GB, Rotmensz N, DeCensi A, Guerrieri-Gonzaga A, Vingiani A, Curigliano G, Zurrida S, Bassi F, Salgado R, Van den Eynden G, Loi S, Denkert C, et al. The prevalence and clinical relevance of tumor-infiltrating lymphocytes (TILs) in ductal carcinoma in situ of the breast. Annals of Oncology : Official Journal of the European Society For Medical Oncology. 28: 321-328. PMID 28426105 DOI: 10.1093/annonc/mdw623 |
0.351 |
|
| 2017 |
De Laere B, van Dam PJ, Whitington T, Mayrhofer M, Diaz EH, Van den Eynden G, Vandebroek J, Del-Favero J, Van Laere S, Dirix L, Grönberg H, Lindberg J. Comprehensive Profiling of the Androgen Receptor in Liquid Biopsies from Castration-resistant Prostate Cancer Reveals Novel Intra-AR Structural Variation and Splice Variant Expression Patterns. European Urology. PMID 28104311 DOI: 10.1016/J.Eururo.2017.01.011 |
0.546 |
|
| 2016 |
Frentzas S, Simoneau E, Bridgeman VL, Vermeulen PB, Foo S, Kostaras E, Nathan MR, Wotherspoon A, Gao ZH, Shi Y, Van den Eynden G, Daley F, Peckitt C, Tan X, Salman A, et al. Vessel co-option mediates resistance to anti-angiogenic therapy in liver metastases. Nature Medicine. PMID 27748747 DOI: 10.1038/Nm.4197 |
0.686 |
|
| 2016 |
Smid M, Rodríguez-González FG, Sieuwerts AM, Salgado R, Prager-Van der Smissen WJ, Vlugt-Daane MV, van Galen A, Nik-Zainal S, Staaf J, Brinkman AB, van de Vijver MJ, Richardson AL, Fatima A, Berentsen K, Butler A, ... ... Van den Eynden GG, et al. Breast cancer genome and transcriptome integration implicates specific mutational signatures with immune cell infiltration. Nature Communications. 7: 12910. PMID 27666519 DOI: 10.1038/ncomms12910 |
0.613 |
|
| 2016 |
Nik-Zainal S, Davies H, Staaf J, Ramakrishna M, Glodzik D, Zou X, Martincorena I, Alexandrov LB, Martin S, Wedge DC, Van Loo P, Ju YS, Smid M, Brinkman AB, Morganella S, ... ... Van den Eynden GG, et al. Landscape of somatic mutations in 560 breast cancer whole-genome sequences. Nature. PMID 27135926 DOI: 10.1038/Nature17676 |
0.641 |
|
| 2016 |
Pastushenko I, Van den Eynden GG, Vicente-Arregui S, Prieto-Torres L, Alvarez-Alegret R, Querol I, Dirix LY, Carapeto FJ, Vermeulen PB, Van Laere SJ. Increased Angiogenesis and Lymphangiogenesis in Metastatic Sentinel Lymph Nodes Is Associated With Nonsentinel Lymph Node Involvement and Distant Metastasis in Patients With Melanoma. The American Journal of Dermatopathology. PMID 26909582 DOI: 10.1097/Dad.0000000000000488 |
0.651 |
|
| 2015 |
Eefsen RL, Engelholm L, Alpizar-Alpizar W, Van den Eynden GG, Vermeulen PB, Christensen IJ, Laerum OD, Rolff HC, Høyer-Hansen G, Vainer B, Osterlind K, Illemann M. Inflammation and uPAR-Expression in Colorectal Liver Metastases in Relation to Growth Pattern and Neo-adjuvant Therapy. Cancer Microenvironment : Official Journal of the International Cancer Microenvironment Society. 8: 93-100. PMID 26268716 DOI: 10.1007/S12307-015-0172-Z |
0.481 |
|
| 2015 |
Pastushenko I, Vermeulen PB, Vicente-Arregui S, Van den Eynden GG, Alvarez-Alegret R, Querol I, Rutten A, Carapeto FJ, Dirix LY, Van Laere S. Peritumoral D2-40 Chalkley score independently predicts metastases and survival in patients with cutaneous malignant melanoma. Journal of Cutaneous Pathology. 42: 699-711. PMID 26264662 DOI: 10.1111/Cup.12571 |
0.645 |
|
| 2015 |
Sonnenblick A, Brohée S, Fumagalli D, Vincent D, Venet D, Ignatiadis M, Salgado R, Van den Eynden G, Rothé F, Desmedt C, Neven P, Loibl S, Denkert C, Joensuu H, Loi S, et al. Constitutive phosphorylated STAT3-associated gene signature is predictive for trastuzumab resistance in primary HER2-positive breast cancer. Bmc Medicine. 13: 177. PMID 26234940 DOI: 10.1186/s12916-015-0416-2 |
0.356 |
|
| 2015 |
Eefsen RL, Vermeulen PB, Christensen IJ, Laerum OD, Mogensen MB, Rolff HC, Van den Eynden GG, Høyer-Hansen G, Osterlind K, Vainer B, Illemann M. Growth pattern of colorectal liver metastasis as a marker of recurrence risk. Clinical & Experimental Metastasis. 32: 369-81. PMID 25822899 DOI: 10.1007/S10585-015-9715-4 |
0.474 |
|
| 2015 |
Pastushenko I, Vicente-Arregui S, Van den Eynden GG, Gracia-Cazaña T, Carapeto FJ, Alvarez-Alegret R, Dirix LY, Vermeulen PB, Van Laere S. Melanomas arising on skin with chronic sun-induced damage exhibit low degree of angiogenesis and lymphangiogenesis. The American Journal of Dermatopathology. 37: 451-4. PMID 25747811 DOI: 10.1097/Dad.0000000000000265 |
0.628 |
|
| 2015 |
Peeters DJ, Brouwer A, Van den Eynden GG, Rutten A, Onstenk W, Sieuwerts AM, Van Laere SJ, Huget P, Pauwels P, Peeters M, Vermeulen PB, Dirix LY. Circulating tumour cells and lung microvascular tumour cell retention in patients with metastatic breast and cervical cancer. Cancer Letters. 356: 872-9. PMID 25449778 DOI: 10.1016/J.Canlet.2014.10.039 |
0.723 |
|
| 2015 |
Salgado R, Denkert C, Demaria S, Sirtaine N, Klauschen F, Pruneri G, Wienert S, Van den Eynden G, Baehner FL, Penault-Llorca F, Perez EA, Thompson EA, Symmans WF, Richardson AL, Brock J, et al. The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014. Annals of Oncology : Official Journal of the European Society For Medical Oncology / Esmo. 26: 259-71. PMID 25214542 DOI: 10.1093/annonc/mdu450 |
0.335 |
|
| 2014 |
Van den Eynden GG, Bird NC, Dirix LY, Eefsen RL, Gao ZH, Høyer-Hansen G, Illemann M, Majeed AW, Metrakos P, Reynolds AR, Vainer B, van Dam PJ, Van Laere SJ, Vermeulen PB, Vidal-Vanaclocha F, et al. Tumor stromal phenotypes define VEGF sensitivity--letter. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 20: 5140. PMID 25274379 DOI: 10.1158/1078-0432.Ccr-14-0158 |
0.622 |
|
| 2014 |
Pastushenko I, Gracia-Cazaña T, Vicente-Arregui S, Van den Eynden GG, Ara M, Vermeulen PB, Carapeto FJ, Van Laere SJ. Squamous cell carcinomas of the skin explore angiogenesis-independent mechanisms of tumour vascularization. Journal of Skin Cancer. 2014: 651501. PMID 24891955 DOI: 10.1155/2014/651501 |
0.634 |
|
| 2014 |
Pastushenko I, Vermeulen PB, Van den Eynden GG, Rutten A, Carapeto FJ, Dirix LY, Van Laere S. Mechanisms of tumour vascularization in cutaneous malignant melanoma: clinical implications. The British Journal of Dermatology. 171: 220-33. PMID 24641095 DOI: 10.1111/Bjd.12973 |
0.674 |
|
| 2014 |
Marsan M, Van den Eynden G, Limame R, Neven P, Hauspy J, Van Dam PA, Vergote I, Dirix LY, Vermeulen PB, Van Laere SJ. A core invasiveness gene signature reflects epithelial-to-mesenchymal transition but not metastatic potential in breast cancer cell lines and tissue samples. Plos One. 9: e89262. PMID 24586640 DOI: 10.1371/Journal.Pone.0089262 |
0.734 |
|
| 2014 |
Peeters DJ, van Dam PJ, Van den Eynden GG, Rutten A, Wuyts H, Pouillon L, Peeters M, Pauwels P, Van Laere SJ, van Dam PA, Vermeulen PB, Dirix LY. Detection and prognostic significance of circulating tumour cells in patients with metastatic breast cancer according to immunohistochemical subtypes. British Journal of Cancer. 110: 375-83. PMID 24366294 DOI: 10.1038/Bjc.2013.743 |
0.739 |
|
| 2014 |
Van den Eynden GG, van Dam PJ, Stroobants S, Dirix L, Vermeulen P. Histopathological evaluation of resected colorectal cancer liver metastases: what should be done? Histopathology. 64: 315-6. PMID 24330151 DOI: 10.1111/his.12259 |
0.483 |
|
| 2014 |
Pastushenko I, Vermeulen PB, Carapeto FJ, Van den Eynden G, Rutten A, Ara M, Dirix LY, Van Laere S. Blood microvessel density, lymphatic microvessel density and lymphatic invasion in predicting melanoma metastases: systematic review and meta-analysis. The British Journal of Dermatology. 170: 66-77. PMID 24134623 DOI: 10.1111/Bjd.12688 |
0.65 |
|
| 2014 |
Sucaet Y, Waelput W, Vermeulen P, Van den Eynden G. Using a Novel Whole Slide Imaging Software Platform for an International Multicenter Validation Study to Assess the Histological Growth Pattern of Liver Metastases Analytical Cellular Pathology. 2014: 1-2. DOI: 10.1155/2014/812391 |
0.482 |
|
| 2013 |
Sleeckx N, Van Brantegem L, Van den Eynden G, Fransen E, Casteleyn C, Van Cruchten S, Veldhuis Kroeze E, Van Ginneken C. Lymphangiogenesis in canine mammary tumours: a morphometric and prognostic study. Journal of Comparative Pathology. 150: 184-93. PMID 24225342 DOI: 10.1016/j.jcpa.2013.09.006 |
0.364 |
|
| 2013 |
Van den Eynden GG, Majeed AW, Illemann M, Vermeulen PB, Bird NC, Høyer-Hansen G, Eefsen RL, Reynolds AR, Brodt P. The multifaceted role of the microenvironment in liver metastasis: biology and clinical implications. Cancer Research. 73: 2031-43. PMID 23536564 DOI: 10.1158/0008-5472.Can-12-3931 |
0.505 |
|
| 2013 |
Peeters DJ, De Laere B, Van den Eynden GG, Van Laere SJ, Rothé F, Ignatiadis M, Sieuwerts AM, Lambrechts D, Rutten A, van Dam PA, Pauwels P, Peeters M, Vermeulen PB, Dirix LY. Semiautomated isolation and molecular characterisation of single or highly purified tumour cells from CellSearch enriched blood samples using dielectrophoretic cell sorting. British Journal of Cancer. 108: 1358-67. PMID 23470469 DOI: 10.1038/Bjc.2013.92 |
0.625 |
|
| 2012 |
Eefsen RL, Van den Eynden GG, Brodt P, Burnier JV, Hoyer-Hansen G, Christensen IJ, Metrakos P, Laerum OD, Federspiel B, Willemoe G, Osterlind K, Illemann M. Growth patterns of liver metastases as compared to resected tumors of the same colorectal cancer patients. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 30: 519. PMID 27983394 DOI: 10.1200/jco.2012.30.4_suppl.519 |
0.312 |
|
| 2012 |
Eefsen RL, Van den Eynden GG, Høyer-Hansen G, Brodt P, Laerum OD, Vermeulen PB, Christensen IJ, Wettergren A, Federspiel B, Willemoe GL, Vainer B, Osterlind K, Illemann M. Histopathological growth pattern, proteolysis and angiogenesis in chemonaive patients resected for multiple colorectal liver metastases. Journal of Oncology. 2012: 907971. PMID 22919385 DOI: 10.1155/2012/907971 |
0.453 |
|
| 2012 |
Van den Eynden GG, Bird NC, Majeed AW, Van Laere S, Dirix LY, Vermeulen PB. The histological growth pattern of colorectal cancer liver metastases has prognostic value. Clinical & Experimental Metastasis. 29: 541-9. PMID 22476470 DOI: 10.1007/S10585-012-9469-1 |
0.649 |
|
| 2011 |
Trinh XB, van Dam PA, Vermeulen PB, Van Laere SJ, Van den Eynden GG, Tjalma WA, Dirix LY. VEGF-A-independent and angiogenesis-dependent tumour growth in patients with metastatic breast cancer. Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico. 13: 805-8. PMID 22082645 DOI: 10.1007/S12094-011-0737-3 |
0.577 |
|
| 2011 |
Peeters DJ, Van den Eynden GG, van Dam PJ, Prové A, Benoy IH, van Dam PA, Vermeulen PB, Pauwels P, Peeters M, Van Laere SJ, Dirix LY. Circulating tumour cells in the central and the peripheral venous compartment in patients with metastatic breast cancer. British Journal of Cancer. 104: 1472-7. PMID 21468046 DOI: 10.1038/Bjc.2011.122 |
0.731 |
|
| 2011 |
Peeters D, van Dam P, Van den Eynden G, Benoy I, Van Laere SJ, van Dam PA, Huget P, Pauwels P, Peeters M, Vermeulen PB, Dirix LY. Detection of circulating tumor cells in patients with advanced breast cancer according to the immunohistochemical subtype. Journal of Clinical Oncology. 29: e21022-e21022. DOI: 10.1200/Jco.2011.29.15_Suppl.E21022 |
0.701 |
|
| 2009 |
Baldewijns MM, van Vlodrop IJ, Smits KM, Vermeulen PB, Van den Eynden GG, Schot F, Roskams T, van Poppel H, van Engeland M, de Bruïne AP. Different angiogenic potential in low and high grade sporadic clear cell renal cell carcinoma is not related to alterations in the von Hippel-Lindau gene. Cellular Oncology : the Official Journal of the International Society For Cellular Oncology. 31: 371-82. PMID 19759417 DOI: 10.3233/Clo-2009-0482 |
0.467 |
|
| 2009 |
Van den Eynden GG, Van Laere SJ, Van der Auwera I, Trinh XB, Van Marck EA, Dirix LY, Vermeulen PB. Two distinct expression patterns of urokinase, urokinase receptor and plasminogen activator inhibitor-1 in colon cancer liver metastases. International Journal of Cancer. 125: 1494-6. PMID 19536843 DOI: 10.1002/ijc.24524 |
0.664 |
|
| 2009 |
Trinh XB, Tjalma WA, Vermeulen PB, Van den Eynden G, Van der Auwera I, Van Laere SJ, Helleman J, Berns EM, Dirix LY, van Dam PA. The VEGF pathway and the AKT/mTOR/p70S6K1 signalling pathway in human epithelial ovarian cancer. British Journal of Cancer. 100: 971-8. PMID 19240722 DOI: 10.1038/Sj.Bjc.6604921 |
0.664 |
|
| 2009 |
Baldewijns MM, Roskams T, Ballet V, Van den Eynden GG, Van Laere SJ, Van der Auwera I, Lerut E, De Bruïne AP, Thijssen VL, Vermeulen PB, van Poppel H. A low frequency of lymph node metastasis in clear-cell renal cell carcinoma is related to low lymphangiogenic activity. Bju International. 103: 1626-31. PMID 19154467 DOI: 10.1111/J.1464-410X.2008.08272.X |
0.628 |
|
| 2008 |
Van Laere S, Beissbarth T, Van der Auwera I, Van den Eynden G, Trinh XB, Elst H, Van Hummelen P, van Dam P, Van Marck E, Vermeulen P, Dirix L. Relapse-free survival in breast cancer patients is associated with a gene expression signature characteristic for inflammatory breast cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 14: 7452-60. PMID 19010862 DOI: 10.1158/1078-0432.Ccr-08-1077 |
0.734 |
|
| 2008 |
Van der Auwera I, Van Laere SJ, Van den Bosch SM, Van den Eynden GG, Trinh BX, van Dam PA, Colpaert CG, van Engeland M, Van Marck EA, Vermeulen PB, Dirix LY. Aberrant methylation of the Adenomatous Polyposis Coli (APC) gene promoter is associated with the inflammatory breast cancer phenotype. British Journal of Cancer. 99: 1735-42. PMID 18841156 DOI: 10.1038/Sj.Bjc.6604705 |
0.68 |
|
| 2008 |
Van den Eynden GG, Smid M, Van Laere SJ, Colpaert CG, Van der Auwera I, Bich TX, van Dam P, den Bakker MA, Dirix LY, Van Marck EA, Vermeulen PB, Foekens JA. Gene expression profiles associated with the presence of a fibrotic focus and the growth pattern in lymph node-negative breast cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 14: 2944-52. PMID 18483361 DOI: 10.1158/1078-0432.Ccr-07-4397 |
0.722 |
|
| 2007 |
Van den Eynden GG, Vandenberghe MK, van Dam PJ, Colpaert CG, van Dam P, Dirix LY, Vermeulen PB, Van Marck EA. Increased sentinel lymph node lymphangiogenesis is associated with nonsentinel axillary lymph node involvement in breast cancer patients with a positive sentinel node. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 13: 5391-7. PMID 17875768 DOI: 10.1158/1078-0432.Ccr-07-1230 |
0.553 |
|
| 2007 |
Van Laere S, Van der Auwera I, Van den Eynden G, Van Hummelen P, van Dam P, Van Marck E, Vermeulen PB, Dirix L. Distinct molecular phenotype of inflammatory breast cancer compared to non-inflammatory breast cancer using Affymetrix-based genome-wide gene-expression analysis. British Journal of Cancer. 97: 1165-74. PMID 17848951 DOI: 10.1038/Sj.Bjc.6603967 |
0.687 |
|
| 2007 |
Van den Eynden GG, Van der Auwera I, Colpaert CG, Dirix LY, Van Marck EA, Vermeulen PB. Letter to the editor: Lymphangiogenesis in primary breast cancer. Cancer Letters. 256: 279-81; author reply. PMID 17714860 DOI: 10.1016/J.Canlet.2007.07.005 |
0.576 |
|
| 2007 |
Van Laere SJ, Van der Auwera I, Van den Eynden GG, van Dam P, Van Marck EA, Vermeulen PB, Dirix LY. NF-kappaB activation in inflammatory breast cancer is associated with oestrogen receptor downregulation, secondary to EGFR and/or ErbB2 overexpression and MAPK hyperactivation. British Journal of Cancer. 97: 659-69. PMID 17700572 DOI: 10.1038/Sj.Bjc.6603906 |
0.658 |
|
| 2007 |
Van den Eynden GG, Van der Auwera I, Van Laere SJ, Trinh XB, Colpaert CG, van Dam P, Dirix LY, Vermeulen PB, Van Marck EA. Comparison of molecular determinants of angiogenesis and lymphangiogenesis in lymph node metastases and in primary tumours of patients with breast cancer. The Journal of Pathology. 213: 56-64. PMID 17674348 DOI: 10.1002/Path.2211 |
0.708 |
|
| 2007 |
Van den Eynden GG, Colpaert CG, Couvelard A, Pezzella F, Dirix LY, Vermeulen PB, Van Marck EA, Hasebe T. A fibrotic focus is a prognostic factor and a surrogate marker for hypoxia and (lymph)angiogenesis in breast cancer: review of the literature and proposal on the criteria of evaluation. Histopathology. 51: 440-51. PMID 17593207 DOI: 10.1111/j.1365-2559.2007.02761.x |
0.616 |
|
| 2007 |
Baldewijns MM, Thijssen VL, Van den Eynden GG, Van Laere SJ, Bluekens AM, Roskams T, van Poppel H, De Bruïne AP, Griffioen AW, Vermeulen PB. High-grade clear cell renal cell carcinoma has a higher angiogenic activity than low-grade renal cell carcinoma based on histomorphological quantification and qRT-PCR mRNA expression profile. British Journal of Cancer. 96: 1888-95. PMID 17505508 DOI: 10.1038/Sj.Bjc.6603796 |
0.652 |
|
| 2007 |
Van den Eynden GG, Van Laere SJ, Van der Auwera I, Gilles L, Burn JL, Colpaert C, van Dam P, Van Marck EA, Dirix LY, Vermeulen PB. Differential expression of hypoxia and (lymph)angiogenesis-related genes at different metastatic sites in breast cancer. Clinical & Experimental Metastasis. 24: 13-23. PMID 17295094 DOI: 10.1007/S10585-006-9049-3 |
0.738 |
|
| 2007 |
Van den Eynden GG, Neyret A, Fumey G, Rizk-Rabin M, Vermeulen PB, Bouizar Z, Body JJ, Dirix LY. PTHrP, calcitonin and calcitriol in a case of severe, protracted and refractory hypercalcemia due to a pancreatic neuroendocrine tumor. Bone. 40: 1166-71. PMID 17188588 DOI: 10.1016/J.Bone.2006.11.009 |
0.407 |
|
| 2006 |
Van den Eynden GG, Van der Auwera I, Van Laere SJ, Huygelen V, Colpaert CG, van Dam P, Dirix LY, Vermeulen PB, Van Marck EA. Induction of lymphangiogenesis in and around axillary lymph node metastases of patients with breast cancer. British Journal of Cancer. 95: 1362-6. PMID 17088912 DOI: 10.1038/Sj.Bjc.6603443 |
0.73 |
|
| 2006 |
Van Laere SJ, Van der Auwera I, Van den Eynden GG, Elst HJ, Weyler J, Harris AL, van Dam P, Van Marck EA, Vermeulen PB, Dirix LY. Nuclear factor-kappaB signature of inflammatory breast cancer by cDNA microarray validated by quantitative real-time reverse transcription-PCR, immunohistochemistry, and nuclear factor-kappaB DNA-binding. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 12: 3249-56. PMID 16740744 DOI: 10.1158/1078-0432.Ccr-05-2800 |
0.709 |
|
| 2006 |
Van den Eynden GG, Van der Auwera I, Van Laere SJ, Colpaert CG, van Dam P, Dirix LY, Vermeulen PB, Van Marck EA. Distinguishing blood and lymph vessel invasion in breast cancer: a prospective immunohistochemical study. British Journal of Cancer. 94: 1643-9. PMID 16670715 DOI: 10.1038/Sj.Bjc.6603152 |
0.703 |
|
| 2006 |
Van Laere SJ, Van den Eynden GG, Van der Auwera I, Vandenberghe M, van Dam P, Van Marck EA, van Golen KL, Vermeulen PB, Dirix LY. Identification of cell-of-origin breast tumor subtypes in inflammatory breast cancer by gene expression profiling. Breast Cancer Research and Treatment. 95: 243-55. PMID 16261404 DOI: 10.1007/S10549-005-9015-9 |
0.713 |
|
| 2006 |
Van den Eynden GG, Van Laere SJ, Van der Auwera I, Merajver SD, Van Marck EA, van Dam P, Vermeulen PB, Dirix LY, van Golen KL. Overexpression of caveolin-1 and -2 in cell lines and in human samples of inflammatory breast cancer. Breast Cancer Research and Treatment. 95: 219-28. PMID 16244790 DOI: 10.1007/S10549-005-9002-1 |
0.73 |
|
| 2005 |
Van der Auwera I, Van den Eynden GG, Colpaert CG, Van Laere SJ, van Dam P, Van Marck EA, Dirix LY, Vermeulen PB. Tumor lymphangiogenesis in inflammatory breast carcinoma: a histomorphometric study. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 11: 7637-42. PMID 16278382 DOI: 10.1158/1078-0432.Ccr-05-1142 |
0.719 |
|
| 2005 |
Van den Eynden GG, Van der Auwera I, Van Laere SJ, Colpaert CG, Turley H, Harris AL, van Dam P, Dirix LY, Vermeulen PB, Van Marck EA. Angiogenesis and hypoxia in lymph node metastases is predicted by the angiogenesis and hypoxia in the primary tumour in patients with breast cancer. British Journal of Cancer. 93: 1128-36. PMID 16251878 DOI: 10.1038/Sj.Bjc.6602828 |
0.713 |
|
| 2005 |
Van Laere S, Van der Auwera I, Van den Eynden GG, Fox SB, Bianchi F, Harris AL, van Dam P, Van Marck EA, Vermeulen PB, Dirix LY. Distinct molecular signature of inflammatory breast cancer by cDNA microarray analysis. Breast Cancer Research and Treatment. 93: 237-46. PMID 16172796 DOI: 10.1007/S10549-005-5157-Z |
0.717 |
|
| 2004 |
Van der Auwera I, Van Laere SJ, Van den Eynden GG, Benoy I, van Dam P, Colpaert CG, Fox SB, Turley H, Harris AL, Van Marck EA, Vermeulen PB, Dirix LY. Increased angiogenesis and lymphangiogenesis in inflammatory versus noninflammatory breast cancer by real-time reverse transcriptase-PCR gene expression quantification. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 10: 7965-71. PMID 15585631 DOI: 10.1158/1078-0432.Ccr-04-0063 |
0.724 |
|
| 2004 |
Stessels F, Van den Eynden G, Van der Auwera I, Salgado R, Van den Heuvel E, Harris AL, Jackson DG, Colpaert CG, van Marck EA, Dirix LY, Vermeulen PB. Breast adenocarcinoma liver metastases, in contrast to colorectal cancer liver metastases, display a non-angiogenic growth pattern that preserves the stroma and lacks hypoxia. British Journal of Cancer. 90: 1429-36. PMID 15054467 DOI: 10.1038/Sj.Bjc.6601727 |
0.51 |
|
| 2004 |
Van den Eynden GG, Van der Auwera I, Van Laere S, Colpaert CG, van Dam P, Merajver S, Kleer CG, Harris AL, Van Marck EA, Dirix LY, Vermeulen PB. Validation of a tissue microarray to study differential protein expression in inflammatory and non-inflammatory breast cancer. Breast Cancer Research and Treatment. 85: 13-22. PMID 15039594 DOI: 10.1023/B:Brea.0000021028.33926.A8 |
0.58 |
|
| 2002 |
Van den Eynden GG, Colpaert CG, Vermeulen PB, Weyler JJ, Goovaerts G, van Dam P, Van Marck EA, Dirix LY. Comparative analysis of the biochemical and immunohistochemical determination of hormone receptors in invasive breast carcinoma influence of the tumor-stroma ratio. Pathology, Research and Practice. 198: 517-24. PMID 12389994 DOI: 10.1078/0344-0338-00295 |
0.497 |
|
| Show low-probability matches. |